Clinical Trials Browser

Lymphatic Diseases × Daunorubicin × Clear all

NCT00715637 2010-10-13

Phase III Randomized Study of Amonafide (AS1413) and Cytarabine Versus Daunorubicin and Cytarabine in Patients With Secondary Acute Myeloid Leukemia (AML)- the ACCEDE Study

Phase 3 Unknown

Other hematologic neoplasm

Leukemia, Lymphatic Diseases